Four Swiss-based companies will received state funding to develop a range of new drugs to treat coronavirus, which are expected to be available by the end of 2022.
This content was published on
1 minute
swissinfo.ch/dos
Português
pt
Governo suíço financia quatro novos medicamentos contra a Covid
The contracts were signed in the context of the Federal Funding Programme for Covid-19 Medicines, run by the Federal Office for Public Health (FOPH) and the Swiss Innovation Agency Innosuisse, the government said on MondayExternal link.
The total value of the four deals is CHF27 million ($29.2 million).
The projects aim to treat a range of the symptoms caused by a Covid-19 infection and to mitigate the length and severity of illness.
Two of the drugs are monoclonal antibody treatments: one for the neuropsychiatric symptoms in sufferers of long Covid, and the other for use on patients at risk of a severe course of Covid-19. A third project is developing an oral pulmonary vasodilator which makers hope will prevent respiratory failure and reduce the need for artificial ventilation.
A final project is an antiviral and anti-inflammatory to treat “all severities of Covid-19”.
Switzerland will enjoy “certain benefits” in return for its investment, the government stated. This includes having a first option on purchases of the drugs.
The government’s medical procurement capabilities to tackle the coronavirus pandemic come under the remit of the Covid-19 law, approved for a second time by voters in a nationwide referendum two weeks ago.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Should Switzerland take measures to support its struggling industries?
Industrial policies are back in fashion, not only in the United States but also in the EU. Should Switzerland, where various industries are struggling, draw inspiration from such policies?
Switzerland announces candidacy to chair OSCE in 2026
This content was published on
Switzerland is officially in the running to chair the Organisation for Security and Cooperation in Europe (OSCE) in 2026, the foreign ministry announced on Thursday.
Switzerland assumes protecting power mandate for Ecuador in Venezuela
This content was published on
At Quito's request, Switzerland will represent Ecuador's interests in Venezuela, the Swiss foreign ministry announced on Thursday.
Swiss researchers find security flaws in AI models
This content was published on
Artificial intelligence (AI) models can be manipulated despite existing safeguards. With targeted attacks, scientists in Lausanne have been able to trick these systems into generating dangerous or ethically dubious content.
Two Swiss nationals indicted for supporting Islamic State
This content was published on
The Office of the Attorney General of Switzerland has filed charges against two Swiss nationals, aged 22 and 28, who are accused of supporting the banned terrorist group Islamic State.
This content was published on
The Swiss parliament has finalised the 2025 federal budget, with the army receiving more money at the expense of foreign aid.
Switzerland expresses sympathy after earthquake hits South Pacific
This content was published on
"Our thoughts are with the people of Vanuatu who are struggling with the consequences of this devastating earthquake," the Swiss embassy in Australia said.
This content was published on
The Swiss agricultural sector is to benefit from greater federal support between 2026 and 2029, after a vote by the House of Representatives on Wednesday.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
It’s not all about age: why Covid hits some people harder than others
This content was published on
New insights: two studies involving Swiss scientists suggest genes and blood sugar levels play a crucial role in the course of Covid-19.
This content was published on
Should we be afraid of virus variants? Will vaccines be effective against new virus forms? Genomic epidemiologist Emma Hodcroft offers some insight.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.